Copy Link Print Information

Tilogotamab

(Synonyms: HexaBody-DR5/DR5; Hx-DR5-01/05)
Customer Review

Based on 1 Customer Validation

Tilogotamab is an agonistic hexamer formation-enhanced mixture of two antibodies that target two separate epitopes on death receptor type 5 (DR5). Tilogotamab specifically binds to and activates DR5. Tilogotamab can be used for the research of multiple myeloma (MM).

For research use only. We do not sell to patients.

  • Purity: 99.31%
  • CAS No.: 2109731-10-2
  • Molecular Weight:144.88 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Tilogotamab
  • Experimental Validation Results for Tilogotamab
  • Experimental Validation Results for Tilogotamab
  • Tilogotamab Chemical Structure
    Tilogotamab Chemical Structure
CAS No.: 2109731-10-2
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Tilogotamab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products
Keywords
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG1 kappa

  • 1/16

    Immobilized Human TNFRSF10B/TRAILR2/CD262, Fc Tag can bind Tilogotamab. The EC50 for this effect is 158.9 ng/mL.

  • 1/16

    Flow cytometric analysis of 1.5X106 HEPG2 cells with Tilogotamab (HY-P99559, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG2 kappa, Isotype Control (HY-P99002, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • Tilogotamab Chemical Structure
    1/16
  • Tilogotamab
  • Immobilized Human TNFRSF10B/TRAILR2/CD262, Fc Tag can bind Tilogotamab. The EC50 for this effect is 158.9 ng/mL.
  • Flow cytometric analysis of 1.5X106 HEPG2 cells with Tilogotamab (HY-P99559, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG2 kappa, Isotype Control (HY-P99002, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).